1. Home
  2. SNEX vs AAPG Comparison

SNEX vs AAPG Comparison

Compare SNEX & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNEX
  • AAPG
  • Stock Information
  • Founded
  • SNEX 1924
  • AAPG 2009
  • Country
  • SNEX United States
  • AAPG China
  • Employees
  • SNEX N/A
  • AAPG N/A
  • Industry
  • SNEX Investment Bankers/Brokers/Service
  • AAPG Biotechnology: Pharmaceutical Preparations
  • Sector
  • SNEX Finance
  • AAPG Health Care
  • Exchange
  • SNEX Nasdaq
  • AAPG Nasdaq
  • Market Cap
  • SNEX 4.4B
  • AAPG 3.6B
  • IPO Year
  • SNEX 1994
  • AAPG 2025
  • Fundamental
  • Price
  • SNEX $91.97
  • AAPG $45.00
  • Analyst Decision
  • SNEX Buy
  • AAPG Buy
  • Analyst Count
  • SNEX 1
  • AAPG 1
  • Target Price
  • SNEX N/A
  • AAPG N/A
  • AVG Volume (30 Days)
  • SNEX 623.0K
  • AAPG 7.2K
  • Earning Date
  • SNEX 08-05-2025
  • AAPG 08-20-2025
  • Dividend Yield
  • SNEX N/A
  • AAPG N/A
  • EPS Growth
  • SNEX 21.85
  • AAPG N/A
  • EPS
  • SNEX 5.86
  • AAPG N/A
  • Revenue
  • SNEX $129,411,800,000.00
  • AAPG $134,352,180.00
  • Revenue This Year
  • SNEX N/A
  • AAPG N/A
  • Revenue Next Year
  • SNEX $13.82
  • AAPG $404.41
  • P/E Ratio
  • SNEX $15.73
  • AAPG N/A
  • Revenue Growth
  • SNEX 53.56
  • AAPG 341.77
  • 52 Week Low
  • SNEX $50.31
  • AAPG $16.50
  • 52 Week High
  • SNEX $100.40
  • AAPG $45.40
  • Technical
  • Relative Strength Index (RSI)
  • SNEX 49.64
  • AAPG N/A
  • Support Level
  • SNEX $80.29
  • AAPG N/A
  • Resistance Level
  • SNEX $93.56
  • AAPG N/A
  • Average True Range (ATR)
  • SNEX 4.32
  • AAPG 0.00
  • MACD
  • SNEX -0.42
  • AAPG 0.00
  • Stochastic Oscillator
  • SNEX 58.08
  • AAPG 0.00

About SNEX StoneX Group Inc.

StoneX Group Inc is a Global brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, Global payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. Its customers include governmental and nongovernmental organizations, commercial banks, brokers, institutional investors, and investment banks. The company operates in the United States, South America, Europe, the Middle East and Asia, and other countries, out of which the majority of revenue is generated from the Middle East and Asia Region.

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

Share on Social Networks: